Captrust Financial Advisors Amgen Inc Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Amgen Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 583,626 shares of AMGN stock, worth $151 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

583,626

Previous 569,373 2.5%

Holding current value

$151 Million

Previous $178 Million 5.71%

% of portfolio

0.57%

Previous 0.58%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $4.41 Million - $4.81 Million	14,253 Added 2.5%	583,626 $188 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $20 Million - $24.3 Million	-76,150 Reduced 11.8%	569,373 $178 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $64.8 Million - $78.3 Million	241,179 Added 59.65%	645,523 $184 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $972,938 - $1.1 Million	3,805 Added 0.95%	404,344 $116 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $289,711 - $359,684	1,325 Added 0.33%	400,539 $108 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2.31 Million - $2.73 Million	10,775 Added 2.77%	399,214 $88.6 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $31,384 - $38,252	-139 Reduced 0.04%	388,439 $93.9 Million
Q4 2022 Feb 15, 2023	BUY	$229.03 - $291.01 $241,397 - $306,724	1,054 Added 0.27%	388,578 $102 Million
Q3 2022 Nov 16, 2022	BUY	$224.46 - $253.15 $11.1 Million - $12.6 Million	49,601 Added 14.68%	387,524 $87.3 Million
Q2 2022 Aug 23, 2022	BUY	$230.71 - $256.74 $77.9 Million - $86.7 Million	337,523 Added 84380.75%	337,923 $82.2 Million
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $71.4 Million - $79.5 Million	-309,621 Reduced 99.87%	400 $97,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $2.74 Million - $3.03 Million	12,497 Added 4.2%	310,021 $75 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $8.69 Million - $9.95 Million	-43,710 Reduced 12.81%	297,524 $66.9 Million
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $4.8 Million - $5.63 Million	22,626 Added 7.1%	341,234 $72.6 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $5.95 Million - $6.6 Million	25,487 Added 8.7%	318,608 $77.7 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $4.66 Million - $5.43 Million	20,999 Added 7.72%	293,121 $72.9 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $4.96 Million - $5.91 Million	22,918 Added 9.2%	272,122 $62.6 Million
Q3 2020 Nov 17, 2020	BUY	$234.65 - $260.95 $2.71 Million - $3.01 Million	11,530 Added 4.85%	249,204 $63.6 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $4.75 Million - $5.83 Million	24,038 Added 11.25%	237,674 $60.6 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $3.18 Million - $4.21 Million	17,425 Added 8.88%	213,636 $42.3 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $32.6 Million - $41.9 Million	172,189 Added 716.8%	196,211 $47.1 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $43,353 - $51,946	249 Added 1.05%	24,022 $4.65 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $2.47 Million - $2.9 Million	14,828 Added 165.77%	23,773 $4.38 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $205,468 - $231,607	-1,136 Reduced 11.27%	8,945 $1.7 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $143,433 - $167,433	-804 Reduced 7.39%	10,081 $1.96 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $660,929 - $745,110	3,567 Added 48.74%	10,885 $2.26 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $4,151 - $4,662	25 Added 0.34%	7,318 $1.35 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $23,889 - $27,918	-141 Reduced 1.9%	7,293 $1.21 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.25 Million - $1.4 Million	7,434	7,434 $1.29 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Amgen Inc Transaction History